Albemarle is trading at $99.00, up 4.24% in pre-market after its November 4 Q3 results beat analyst expectations.

  • Adjusted EPS was $2.58 and sales were $1.55 billion.
  • Higher Energy Storage pricing and productivity improvements supported results.
  • Albemarle raised its full-year Specialties adjusted EBITDA outlook and reduced its capital expenditure forecast.